Your browser doesn't support javascript.
loading
Phase 1b study to assess the safety, tolerability, and clinical activity of pamiparib in combination with temozolomide in patients with locally advanced or metastatic solid tumors.
Stradella, Agostina; Johnson, Melissa; Goel, Sanjay; Park, Haeseong; Lakhani, Nehal; Arkenau, Hendrik-Tobias; Galsky, Matthew D; Calvo, Emiliano; Baz, Vicente; Moreno, Victor; Saavedra, Omar; Luen, Stephen J; Mu, Song; Wan, Qiting; Chang, Victoria; Zhang, Wa; Barve, Minal.
Affiliation
  • Stradella A; Institut Català d'Oncologia-Hospital Duran I Reynals, L'Hospitalet de Llobregat, Catalunya, Spain.
  • Johnson M; Sarah Cannon Research Institute, Tennessee Oncology, PLLC, Nashville, Tennessee, USA.
  • Goel S; Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA.
  • Park H; Washington University School of Medicine, St. Louis, Missouri, USA.
  • Lakhani N; Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Arkenau HT; START Midwest, Grand Rapids, Michigan, USA.
  • Galsky MD; Sarah Cannon Research Institute, UCL Cancer Institute, University College London, London, UK.
  • Calvo E; The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Baz V; START Madrid-HM CIOCC, Centro Integral Oncológico Clara Campal, Hospital Universitario HM Sanchinarro, Calle Oña, Madrid, Spain.
  • Moreno V; Hospital Universitario Virgen Macarena, Seville, Spain.
  • Saavedra O; START Madrid-FJD, Fundacion Jimenez Diaz University Hospital, Madrid, Spain.
  • Luen SJ; Vall d'Hebron Institute of Oncology, Barcelona, Spain.
  • Mu S; Division of Cancer Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Wan Q; The Sir Peter MacCallum Department of Medical Oncology, The University of Melbourne, Melbourne, Victoria, Australia.
  • Chang V; BeiGene, USA Inc, Ridgefield Park, New Jersey, USA.
  • Zhang W; BeiGene (Beijing) Co., Ltd, Beijing, China.
  • Barve M; BeiGene, USA Inc, San Mateo, California, USA.
Cancer Med ; 13(13): e7385, 2024 Jul.
Article in En | MEDLINE | ID: mdl-38970256
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Benzimidazoles / Antineoplastic Combined Chemotherapy Protocols / Maximum Tolerated Dose / Temozolomide / Neoplasms Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Cancer Med Year: 2024 Document type: Article Affiliation country: España Country of publication: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Benzimidazoles / Antineoplastic Combined Chemotherapy Protocols / Maximum Tolerated Dose / Temozolomide / Neoplasms Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Cancer Med Year: 2024 Document type: Article Affiliation country: España Country of publication: Estados Unidos